our_people1.jpg

Peter Gray

Chairman

  • R
  • N

Peter Gray

Chairman

Peter Gray (63) is Chairman and non-executive director of UDG Healthcare. Peter formerly held senior executive positions in a number of Irish public companies, the most recent being that of Vice Chairman and Chief Executive of ICON plc, the Irish based multinational pharmaceutical development services company.

Peter Gray sits on the following committees:

Brendan-McAtamney.jpg

Brendan McAtamney

Chief Executive

Brendan McAtamney

Chief Executive

Brendan McAtamney (55) was appointed Group Chief Executive Officer on 2 February 2016, having previously served as the Group’s Chief Operating Officer since 1 September 2013. Before joining UDG Healthcare, Brendan held various senior management positions with Abbott, latterly as Vice President Commercial and Corporate Officer within the Established Pharmaceuticals division.

Alan-Ralph.jpg

Alan Ralph

Chief Financial Officer

Alan Ralph

Chief Financial Officer

Alan Ralph (48) joined UDG Healthcare in 1999 and was appointed Chief Financial Officer on 1 June 2013. Alan previously had responsibility for the Supply Chain Services division which was sold in 2016. Alan also held various roles throughout the Group including Managing Director of the Pharma Wholesale division and Group Financial Controller. Prior to working with the Group, Alan worked with Banta Corporation and PriceWaterhouseCoopers.

Chris-Corbin.jpg

Chris Corbin

CHAIRMAN OF ASHFIELD

Chris Corbin

CHAIRMAN OF ASHFIELD

Chris Corbin (62) is executive Chairman of the Ashfield division, having previously served as Managing Director of Ashfield. Chris founded Ashfield Healthcare Limited and previously held sales management positions with Parke Davis, Fisons, Astra and May & Baker. Chris was formerly Patron for SETPOINT Leicestershire, Chairman of Leicestershire Business Awards and a member of Derbyshire Magistrates Bench.

Chris-Brinsmead.jpg

Chris Brinsmead CBE

Senior Independent Non-Executive Director

  • R
  • R
  • N

Chris Brinsmead CBE

Senior Independent Non-Executive Director

Chris Brinsmead CBE (58) was formerly Chairman of AstraZeneca Pharmaceuticals UK, President of AstraZeneca UK and Ireland and President of the Association of the British Pharmaceutical Industry (ABPI). Chris succeeded Philip Toomey as Senior Independent non-executive Director on 1 July 2017.

Chris Brinsmead CBE sits on the following committees:

Lisa-Ricci.jpg

Lisa Ricciardi

Non-Executive Director

  • R
  • R

Lisa Ricciardi

Non-Executive Director

Lisa Ricciardi (57) was recently appointed Chief Operating Officer of ContraFect Corporation, a NASDAQ company. Lisa was formerly Senior Vice President of Foundation Medicine, Inc. and prior to this was Senior Vice President of US and International Business Development at Medco Health Solutions. Lisa also held multiple senior roles in Pfizer, first in operations then leading business development for over a decade.

Lisa Ricciardi sits on the following committees:

Linda-Wilding.jpg

Linda Wilding

Non-Executive Director

  • A
  • R
  • N

Linda Wilding

Non-Executive Director

Linda Wilding’s (58) career includes 12 years at Mercury Asset Management where she held the position of Managing Director in the Private Equity division. Prior to this, Linda qualified as a chartered accountant while working with Ernst & Young

Linda Wilding sits on the following committees:

Phil-Toomey.jpg

Philip Toomey

Non-Executive Director

  • R
  • N

Philip Toomey

Non-Executive Director

Philip Toomey (64) was appointed a nonexecutive director of UDG Healthcare on 27 February 2008 and held the position of Senior Independent nonexecutive Director from 14 June 2013 until 30 June 2017. Philip was formerly Global Chief Operating Officer for the financial services industry practice of Accenture. Philip has wide ranging international consulting experience and was a member of the Accenture Global Leadership Council.

Philip Toomey sits on the following committees:

miller-rich-nancy.jpg

Nancy Miller-Rich

NON-EXECUTIVE DIRECTOR

  • R

Nancy Miller-Rich

NON-EXECUTIVE DIRECTOR

Nancy Miller-Rich (58) was formerly Senior VicePresident, Business Development & Licensing, Strategy and Commercial Support for Global Human Health at MSD, known as Merck in the US and Canada until her retirement in September 2017. With more than 35 years’ experience in the healthcare industry, Nancy’s background includes roles in sales, marketing, and business development for MSD, Schering-Plough, Sandoz (now Novartis), and Sterling Drug.

Nancy Miller-Rich sits on the following committees:

Myles-Lee-April-2017teal.jpg (1)

Myles Lee

Non-executive Director

  • A
  • N

Myles Lee

Non-executive Director

Myles (64) was Group Chief Executive of CRH plc, a FTSE 100 and Fortune 500 company, prior to retiring in December 2013. With more than 30 years’ experience at senior financial and managerial level, Myles has extensive global experience in management, M&A and finance. He is a qualified civil engineer and a Fellow of the Institute of Chartered Accountants in Ireland.

Myles Lee sits on the following committees: